Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders

被引:54
作者
Alajangi, Hema Kumari [1 ,2 ]
Kaur, Mandeep [1 ]
Sharma, Akanksha [1 ,2 ]
Rana, Sumedh [1 ]
Thakur, Shipali [1 ]
Chatterjee, Mary [3 ]
Singla, Neha [1 ]
Jaiswal, Pradeep Kumar [4 ]
Singh, Gurpal [2 ]
Barnwal, Ravi Pratap [1 ]
机构
[1] Panjab Univ, Dept Biophys, Chandigarh 160014, India
[2] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
[3] Panjab Univ, Dept Biotechnol, UIET, Chandigarh 160014, India
[4] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA
关键词
Blood-brain barrier; BBB dysfunction; Drug delivery; Nanoparticles; Central nervous system; Neurological diseases; PEGYLATED LIPOSOMAL DOXORUBICIN; SOLID LIPID NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; PEG-PLA NANOPARTICLES; DRUG-DELIVERY; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; IN-VITRO; AUTOIMMUNE DISORDERS; SIGNALING PATHWAYS;
D O I
10.1186/s13041-022-00937-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The integrity of the blood-brain barrier (BBB) is essential for normal central nervous system (CNS) functioning. Considering the significance of BBB in maintaining homeostasis and the neural environment, we aim to provide an overview of significant aspects of BBB. Worldwide, the treatment of neurological diseases caused by BBB disruption has been a major challenge. BBB also restricts entry of neuro-therapeutic drugs and hinders treatment modalities. Hence, currently nanotechnology-based approaches are being explored on large scale as alternatives to conventional methodologies. It is necessary to investigate the in-depth characteristic features of BBB to facilitate the discovery of novel drugs that can successfully cross the barrier and target the disease effectively. It is imperative to discover novel strategies to treat life-threatening CNS diseases in humans. Therefore, insights regarding building blocks of BBB, activation of immune response on breach of this barrier, and various autoimmune neurological disorders caused due to BBB dysfunction are discussed. Further, special emphasis is given on delineating BBB disruption leading to CNS disorders. Moreover, various mechanisms of transport pathways across BBB, several novel strategies, and alternative routes by which drugs can be properly delivered into CNS are also discussed.
引用
收藏
页数:28
相关论文
共 247 条
  • [51] The Blood-Brain Barrier
    Daneman, Richard
    Prat, Alexandre
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (01):
  • [52] Regulation of Redox-Sensitive Signaling Pathways in Rat Primary Astrocytes Following Acrolein Exposure
    Dang Thanh Nam
    Arseneault, Madeleine
    Ramassamy, Charles
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (02) : 263 - 277
  • [53] Astrocytic Dysfunction in Epileptogenesis: Consequence of Altered Potassium and Glutamate Homeostasis?
    David, Yaron
    Cacheaux, Luisa P.
    Ivens, Sebastian
    Lapilover, Ezequiel
    Heinemann, Uwe
    Kaufer, Daniela
    Friedman, Alon
    [J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (34) : 10588 - 10599
  • [54] Davis Larry E, 2018, Continuum (Minneap Minn), V24, P1264, DOI 10.1212/CON.0000000000000660
  • [55] Drug targeting to the brain
    de Boer, A. G.
    Gaillard, P. J.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 : 323 - 355
  • [56] Brain-Reactive Antibodies and Disease
    Diamond, B.
    Honig, G.
    Mader, S.
    Brimberg, L.
    Volpe, B. T.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 31, 2013, 31 : 345 - 385
  • [57] Mast Cells and Neuroinflammation
    Dong, Hongquan
    Zhang, Xiang
    Qian, Yanning
    [J]. MEDICAL SCIENCE MONITOR BASIC RESEARCH, 2014, 20 : 200 - 206
  • [58] Group B streptococcal β-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis
    Doran, KS
    Liu, GY
    Nizet, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) : 736 - 744
  • [59] Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology
    Drouin-Ouellet, Janelle
    Sawiak, Stephen J.
    Cisbani, Giulia
    Lagace, Marie
    Kuan, Wei-Li
    Saint-Pierre, Martine
    Dury, Richard J.
    Alata, Wael
    St-Amour, Isabelle
    Mason, Sarah L.
    Calon, Frederic
    Lacroix, Steve
    Gowland, Penny A.
    Francis, Susan T.
    Barker, Roger A.
    Cicchetti, Francesca
    [J]. ANNALS OF NEUROLOGY, 2015, 78 (02) : 160 - 177
  • [60] A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
    Duan, Yongtao
    Dhar, Abhishek
    Patel, Chetan
    Khimani, Mehul
    Neogi, Swarnali
    Sharma, Prolay
    Kumar, Nadavala Siva
    Vekariya, Rohit L.
    [J]. RSC ADVANCES, 2020, 10 (45) : 26777 - 26791